» Articles » PMID: 10024356

Activation of Human D3 Dopamine Receptor Inhibits P/Q-type Calcium Channels and Secretory Activity in AtT-20 Cells

Overview
Journal J Neurosci
Specialty Neurology
Date 1999 Feb 19
PMID 10024356
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The D3 dopamine receptor is postulated to play an important role in the regulation of neurotransmitter secretion at both pre- and postsynaptic terminals. However, this hypothesis and the underlying mechanisms remain untested because of the lack of D3-selective ligands, paucity of appropriate model secretory systems, and the weak and inconsistent coupling of D3 receptors to classical signal transduction pathways. The absence of ligands that selectively discriminate between D3 and D2 receptors in vivo precludes the study of D3 receptor function in the brain and necessitates the use of heterologous expression systems. In this report we demonstrate that activation of the human D3 dopamine receptor expressed in the AtT-20 neuroendocrine cell line causes robust inhibition of P/Q-type calcium channels via pertussis toxin-sensitive G-proteins. In addition, using the vesicle trafficking dye FM1-43, we show that D3 receptor activation significantly inhibits spontaneous secretory activity in these cells. Our results not only support the hypothesis that the D3 receptor can regulate secretory activity but also provide insight into the underlying signaling mechanisms. We propose a functional model in which the D3 receptor tightly regulates neurotransmitter release at a synapse by only allowing the propagation of spikes above a certain frequency or burst-duration threshold.

Citing Articles

The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions.

Tsentsevitsky A, Khuzakhmetova V, Bukharaeva E, Petrov A Neurochem Res. 2023; 49(2):453-465.

PMID: 37897557 DOI: 10.1007/s11064-023-04052-1.


Abnormalities of Dopamine D Receptor Signaling in the Diseased Brain.

Prieto G J Cent Nerv Syst Dis. 2017; 9:1179573517726335.

PMID: 28855798 PMC: 5562332. DOI: 10.1177/1179573517726335.


Advances and challenges in the search for D and D dopamine receptor-selective compounds.

Moritz A, Free R, Sibley D Cell Signal. 2017; 41:75-81.

PMID: 28716664 PMC: 5722689. DOI: 10.1016/j.cellsig.2017.07.003.


Striatal dopamine neurotransmission: regulation of release and uptake.

Sulzer D, Cragg S, Rice M Basal Ganglia. 2016; 6(3):123-148.

PMID: 27141430 PMC: 4850498. DOI: 10.1016/j.baga.2016.02.001.


An amino acid residue in the second extracellular loop determines the agonist-dependent tolerance property of the human D3 dopamine receptor.

Gil-Mast S, Kortagere S, Kota K, Kuzhikandathil E ACS Chem Neurosci. 2013; 4(6):940-51.

PMID: 23477444 PMC: 3689203. DOI: 10.1021/cn3002202.


References
1.
Patel Y, Panetta R, Escher E, Greenwood M, Srikant C . Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem. 1994; 269(2):1506-9. View

2.
Momiyama T, Amano T, Todo N, Sasa M . Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area. Eur J Pharmacol. 1996; 310(1):1-8. DOI: 10.1016/0014-2999(96)00350-0. View

3.
Wu L, Saggau P . Pharmacological identification of two types of presynaptic voltage-dependent calcium channels at CA3-CA1 synapses of the hippocampus. J Neurosci. 1994; 14(9):5613-22. PMC: 6577093. View

4.
Reisine T, Wang H, Guild S . Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population. J Pharmacol Exp Ther. 1988; 245(1):225-31. View

5.
Winkler A, Papsdorf G, Odarjuk J, Siems W, Fickel J, Melzig M . Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharmacol. 1995; 291(1):51-5. DOI: 10.1016/0922-4106(95)90188-4. View